Status:

COMPLETED

Bifocal & Atropine in Myopia (BAM) Study

Lead Sponsor:

Jenny Jones

Conditions:

Refractive Errors

Eligibility:

All Genders

7-11 years

Phase:

NA

Brief Summary

This study will test whether the combined treatment of 0.01% atropine and soft bifocal contact lens wear produces slower myopia progression and axial elongation compared to soft bifocal contact lenses...

Detailed Description

Both atropine and soft bifocal contact lenses have been shown to slow myopia progression, and both can cause changes in choroidal thickness. But the relationship between these mechanisms is unclear. T...

Eligibility Criteria

Inclusion

  • 7 to 11 years, inclusive, at baseline examination
  • -0.75 to -5.00 D, inclusive, spherical component, cycloplegic autorefraction
  • ≤1.00 DC, cycloplegic autorefraction
  • ≤ 2.00 D difference between the sphere components of the two eyes (anisometropia), cycloplegic autorefraction
  • 1 logMAR or better best-corrected visual acuity in each eye
  • 1 logMAR or better visual acuity OU distance and near with a +2.50 D add contact lens
  • +2.50 D add lens provides adequate fit with respect to movement and centration
  • Finish at least 71% of 0.01% atropine during the run-in period

Exclusion

  • Eye disease or binocular vision problems (e.g., strabismus, amblyopia, oculomotor nerve palsies, corneal disease, etc.)
  • Previous intraocular or corneal surgery
  • Systemic disease that may affect vision, vision development, or contact lens wear (eg, diabetes, Down syndrome, etc.)
  • Previous gas permeable, soft bifocal, or orthokeratology contact lens wear or bifocal/PAL spectacle wear (longer than 1 month of wear)
  • Previous or current participation in myopia control studies
  • Chronic use of medications that may affect immunity, such as oral or ophthalmic corticosteroids for ocular or systemic diseases
  • Issues that may interfere with the ability to participate over the next 3 years

Key Trial Info

Start Date :

July 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2020

Estimated Enrollment :

49 Patients enrolled

Trial Details

Trial ID

NCT03312257

Start Date

July 1 2016

End Date

June 1 2020

Last Update

December 9 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.